Categories: CHF

AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Lausanne, Switzerland, November 3, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported results …
Read Full Story at source (may require registration)

Latest posts by Business Editor (see all)
Business Editor

Leave a Comment
Share
Published by
Business Editor
1 year ago

Recent Posts

The opinion of the Supervisory Board of Enefit Green AS on the voluntary takeover bid made by Eesti Energia AS on 8 April 2025.

Hereby we publish the opinion of the Supervisory Board of Enefit Green AS on the…

56 minutes ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI

NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…

16 hours ago

Writer/painter-turned cultural heritage preserver behind Spring Festival’s UNESCO heritage status success

Global Times: Feng Jicai leads efforts to preserve China's cultural heritage through art, literature, and…

17 hours ago

Boston Hemp Launches New Line of Premium THCa Concentrates

Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in…

17 hours ago

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BKKT

NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…

18 hours ago

Kyndryl Announcement: If You Have Suffered Losses in Kyndryl Holdings, Inc. (NYSE: KD), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor…

18 hours ago

This website uses cookies.